Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Miles

Showing results (391-400 of 501) with videos related to

Pageof 51
Sort By:
Internal Medicine Journal|October 20, 2021
Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma AllianceGreg Hapgood, Maya Latimer, Sze Ting Lee, et al.
The Australasian Journal of Dermatology|July 12, 2018
Psoriasis and cancer. An Australian/New Zealand narrativeMarius Rademaker, Diana M Rubel, Karen Agnew, et al.
American Journal of Medical Genetics. Part A|April 3, 2008
Development and validation of a measure of dysmorphology: useful for autism subgroup classificationJudith H Miles, T Nicole Takahashi, Julie Hong, et al.
Blood|September 14, 2011
A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myelomaSimon J Harrison, Hang Quach, Emma Link, et al.
Cancer Immunology Research|February 26, 2015
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target CellsAlexander J Davenport, Misty R Jenkins, Ryan S Cross, et al.
Surgery|August 1, 1989
Local skin burn causes systemic (lung and kidney) endothelial cell injury reflected by increased circulating and decreased tissue factor VIII-related antigenM A Gross, D E Viders, J M Brown, et al.
Leukemia & Lymphoma|July 5, 2013
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantSimon J Harrison, Andy K Hsu, Paul Neeson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: results of a phase II trialMadeleine Duvic, Reinhard Dummer, Jürgen C Becker, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2017
The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancersDevesh Oberoi, Victoria M White, John F Seymour, et al.
Plos One|August 21, 2012
Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individualsShuo Li, Stuart Roberts, Magdalena Plebanski, et al.
Pageof 51

Showing results (391-400 of 501) with videos related to

Sort By:
Pageof 51
Internal Medicine Journal|October 20, 2021
Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma AllianceGreg Hapgood, Maya Latimer, Sze Ting Lee, et al.
The Australasian Journal of Dermatology|July 12, 2018
Psoriasis and cancer. An Australian/New Zealand narrativeMarius Rademaker, Diana M Rubel, Karen Agnew, et al.
American Journal of Medical Genetics. Part A|April 3, 2008
Development and validation of a measure of dysmorphology: useful for autism subgroup classificationJudith H Miles, T Nicole Takahashi, Julie Hong, et al.
Blood|September 14, 2011
A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myelomaSimon J Harrison, Hang Quach, Emma Link, et al.
Cancer Immunology Research|February 26, 2015
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target CellsAlexander J Davenport, Misty R Jenkins, Ryan S Cross, et al.
Surgery|August 1, 1989
Local skin burn causes systemic (lung and kidney) endothelial cell injury reflected by increased circulating and decreased tissue factor VIII-related antigenM A Gross, D E Viders, J M Brown, et al.
Leukemia & Lymphoma|July 5, 2013
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantSimon J Harrison, Andy K Hsu, Paul Neeson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: results of a phase II trialMadeleine Duvic, Reinhard Dummer, Jürgen C Becker, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2017
The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancersDevesh Oberoi, Victoria M White, John F Seymour, et al.
Plos One|August 21, 2012
Induction of multi-functional T cells in a phase I clinical trial of dendritic cell immunotherapy in hepatitis C virus infected individualsShuo Li, Stuart Roberts, Magdalena Plebanski, et al.
Pageof 51